Europe Throat Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Description

List of Tables

Europe throat cancer diagnostics market is projected to register a substantial CAGR of 6.7% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Europe Throat Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, and Others), Cancer Type (Pharyngeal Cancer and Laryngeal Cancer), Stages (Stage 0, Stage I, Stage II, Stage III and Stage IV), Age Group (30-65, 65 and above, 21-29 and Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes and Others) and By Distribution Channel (Direct Tender and Retail Sales), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe), Industry Trends and Forecast to 2030.

Strategic initiatives by major market players

Increasing awareness of throat cancer

Market Players:

Some of the key market players in the Europe throat cancer diagnostics market are listed below:

F. Hoffmann-La Roche Ltd.

FUJIFILM Corporation

Thermo Fisher Scientific Inc.

CANON MEDICAL SYSTEMS CORPORATION

Koninklijke Philips N.V.

Merck KGaA

General Electric Company

Illumina

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Abbott

QIAGEN

Siemens Healthcare GmbH

Myriad Genetics Inc.

Quest Diagnostics Incorporated

Hologic

FONAR Corp.

Medonica Co. LTD

SternMed GmbH

MinFound Medical Systems Co., Ltd

PlexBio

1 INTRODUCTION 46

1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 46
1.3 OVERVIEW OF THE EUROPE THROAT CANCER DIAGNOSTICS MARKET 46
1.4 LIMITATIONS 48
1.5 MARKETS COVERED 48

2 MARKET SEGMENTATION 51

2.1 MARKETS COVERED 51
2.2 GEOGRAPHICAL SCOPE 52
2.3 YEARS CONSIDERED FOR THE STUDY 53
2.4 CURRENCY AND PRICING 53
2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
2.6 MULTIVARIATE MODELLING 57
2.7 PRODUCT TYPE LIFELINE CURVE 57
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
2.9 DBMR MARKET POSITION GRID 59
2.10 MARKET END USER COVERAGE GRID 60
2.11 VENDOR SHARE ANALYSIS 61
2.12 SECONDARY SOURCES 62
2.13 ASSUMPTIONS 62

3 EXECUTIVE SUMMARY 63

4 PREMIUM INSIGHTS 66

4.1 PESTEL ANALYSIS 67
4.2 PORTER'S FIVE FORCES 68

5 INDUSTRY INSIGHTS 69

6 EPIDEMIOLOGY 70

7 EUROPE THROAT CANCER DIAGNOSTICS MARKET, REGULATIONS 71

7.1 REGULATORY SCENARIO IN THE U.S 71
7.2 REGULATORY SCENARIO IN AUSTRALIA 72
7.3 REGULATORY SCENARIO IN JAPAN 72
7.4 REGULATORY SCENARIO IN CHINA 72

8 MARKET OVERVIEW 74

8.1 DRIVERS 76
- 8.1.1 GROWING PREVALENCE OF THROAT CANCER 76
- 8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN THROAT CANCER DIAGNOSTICS 76
- 8.1.3 INCREASE IN AWARENESS REGARDING THROAT CANCER 77
8.2 RESTRAINTS 77
- 8.2.1 LATE DIAGNOSIS AND POOR PROGNOSIS OF THROAT CANCER 77
- 8.2.2 HIGH COST FOR THE INSTALLATION OF DIAGNOSTIC DEVICES. 77
8.3 OPPORTUNITIES 78
- 8.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 78
- 8.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 79
- 8.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 79
8.4 CHALLENGES 80
- 8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 80
- 8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 80

9 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 81

9.1 OVERVIEW 82
9.2 INSTRUMENTS 85
- 9.2.1 PATHOLOGY-BASED INSTRUMENTS 86
  - 9.2.1.1 PCR INSTRUMENTS 86
  - 9.2.1.2 SLIDE STAINING SYSTEMS 86
  - 9.2.1.3 TISSUE PROCESSING SYSTEMS 87
  - 9.2.1.4 CELL PROCESSORS 87
  - 9.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 87
- 9.2.2 IMAGING INSTRUMENTS 87
  - 9.2.2.1 ULTRASOUND SYSTEMS 87
  - 9.2.2.2 CT SYSTEMS 87
  - 9.2.2.3 MRI SYSTEMS 87
  - 9.2.2.4 OTHERS 88
- 9.2.3 BIOPSY INSTRUMENTS 88
- 9.2.4 OTHERS 88
9.3 CONSUMABLES & ACCESSORIES 88
- 9.3.1 KITS 89
  - 9.3.1.1 PCR KITS 89
  - 9.3.1.2 DNA POLYMERASE KITS 89
  - 9.3.1.3 NUCLEIC ACID ISOLATION KITS 89
  - 9.3.1.4 OTHERS 90
- 9.3.2 REAGENTS 90
  - 9.3.2.1 ASSAYS 90
  - 9.3.2.2 BUFFERS 90
  - 9.3.2.3 PRIMERS 90
  - 9.3.2.4 OTHERS 90
- 9.3.3 PROBES 90
- 9.3.4 OTHER CONSUMABLES 90

10 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE 91

10.1 OVERVIEW 92
10.2 IMAGING TEST 95
- 10.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 96
- 10.2.2 MRI 96
- 10.2.3 CHEST X-RAY 96
- 10.2.4 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 96
- 10.2.5 OTHERS 96
10.3 BLOOD TEST 96
- 10.3.1 BLOOD CHEMISTRY TESTS 98
- 10.3.2 COMPLETE BLOOD COUNT (CBC) 98
- 10.3.3 OTHERS 98
10.4 BIOPSY 98
- 10.4.1 ENDOSCOPIC BIOPSY 99
- 10.4.2 FINE NEEDLE ASPIRATION (FNA) BIOPSY 99
- 10.4.3 OTHERS 99
10.5 OTHERS 100

11 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 101

11.1 OVERVIEW 102
11.2 PHARYNGEAL CANCER 105
- 11.2.1 NASOPHARYNGEAL CANCER 106
- 11.2.2 OROPHARYNGEAL CANCER 106
- 11.2.3 HYPOPHARYNGEAL CANCER 106
11.3 LARYNGEAL CANCER 107

12 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY STAGES 108

12.1 OVERVIEW 109
12.2 STAGE III 112
12.3 STAGE II 112
12.4 STAGE IV 113
12.5 STAGE I 114
12.6 STAGE 0 115

13 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY AGE 116

13.1 OVERVIEW 117
13.2 30-65 120
13.3 65 AND ABOVE 121
13.4 21-29 121
13.5 BELOW 21 122

14 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY END USER 123

14.1 OVERVIEW 124
14.2 HOSPITALS 127
14.3 ASSOCIATED LABS 127
14.4 INDEPENDENT DIAGNOSTIC LABORATORIES 128
14.5 DIAGNOSTIC IMAGING CENTERS 129
14.6 CANCER RESEARCH INSTITUTES 130
14.7 OTHERS 131

15 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 132

15.1 OVERVIEW 133
15.2 DIRECT TENDER 136
15.3 RETAIL SALES 137

16 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY REGION 138

16.1 EUROPE 139
- 16.1.1 GERMANY 149
- 16.1.2 FRANCE 154
- 16.1.3 U.K. 159
- 16.1.4 ITALY 164
- 16.1.5 SPAIN 169
- 16.1.6 RUSSIA 174
- 16.1.7 TURKEY 179
- 16.1.8 NETHERLANDS 184
- 16.1.9 BELGIUM 189
- 16.1.10 SWITZERLAND 194
- 16.1.11 REST OF EUROPE 199

17 EUROPE THROAT CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 200

17.1 COMPANY SHARE ANALYSIS: EUROPE 200

18 SWOT ANALYSIS 201

19 COMPANY PROFILE 202

19.1 F. HOFFMANN- LA ROCHE LTD 202
- 19.1.1 COMPANY SNAPSHOT 202
- 19.1.2 REVENUE ANALYSIS 202
- 19.1.3 COMPANY SHARE ANALYSIS 203
- 19.1.4 PRODUCT PORTFOLIO 203
- 19.1.5 RECENT DEVELOPMENT 203
19.2 FUJIFILM CORPORATION 204
- 19.2.1 COMPANY SNAPSHOT 204
- 19.2.2 REVENUE ANALYSIS 204
- 19.2.3 COMPANY SHARE ANALYSIS 205
- 19.2.4 PRODUCT PORTFOLIO 205
- 19.2.5 RECENT DEVELOPMENT 205
19.3 THERMO FISHER SCIENTIFIC INC. 206
- 19.3.1 COMPANY SNAPSHOT 206
- 19.3.2 REVENUE ANALYSIS 206
- 19.3.3 COMPANY SHARE ANALYSIS 207
- 19.3.4 PRODUCT PORTFOLIO 207
- 19.3.5 RECENT DEVELOPMENTS 207
19.4 CANON MEDICAL SYSTEMS CORPORATION 208
- 19.4.1 COMPANY SNAPSHOT 208
- 19.4.2 REVENUE ANALYSIS 208
- 19.4.3 COMPANY SHARE ANALYSIS 209
- 19.4.4 PRODUCT PORTFOLIO 209
- 19.4.5 RECENT DEVELOPMENT 209
19.5 KONINKLIJKE PHILIPS N.V. 210
- 19.5.1 COMPANY SNAPSHOT 210
- 19.5.2 REVENUE ANALYSIS 210
- 19.5.3 COMPANY SHARE ANALYSIS 211
- 19.5.4 PRODUCT PORTFOLIO 211
- 19.5.5 RECENT DEVELOPMENT 212
19.6 ABBOTT 213
- 19.6.1 COMPANY SNAPSHOT 213
- 19.6.2 REVENUE ANALYSIS 213
- 19.6.3 PRODUCT PORTFOLIO 214
- 19.6.4 RECENT DEVELOPMENTS 214
19.7 AGILENT TECHNOLOGIES, INC. 215
- 19.7.1 COMPANY SNAPSHOT 215
- 19.7.2 REVENUE ANALYSIS 215
- 19.7.3 PRODUCT PORTFOLIO 216
- 19.7.4 RECENT DEVELOPMENT 216
19.8 BD 217
- 19.8.1 COMPANY SNAPSHOT 217
- 19.8.2 REVENUE ANALYSIS 217
- 19.8.3 PRODUCT PORTFOLIO 218
- 19.8.4 RECENT DEVELOPMENTS 218
19.9 BEIJING O&D BIOTECH CO., LTD. 219
- 19.9.1 COMPANY SNAPSHOT 219
- 19.9.2 PRODUCT PORTFOLIO 219
- 19.9.3 RECENT DEVELOPMENT 219
19.10 BIO-RAD LABORATORIES, INC. 220
- 19.10.1 COMPANY SNAPSHOT 220
- 19.10.2 REVENUE ANALYSIS 220
- 19.10.3 PRODUCT PORTFOLIO 221
- 19.10.4 RECENT DEVELOPMENT 221
19.11 FONAR CORP. 222
- 19.11.1 COMPANY SNAPSHOT 222
- 19.11.2 REVENUE ANALYSIS 222
- 19.11.3 PRODUCT PORTFOLIO 223
- 19.11.4 RECENT DEVELOPMENT 223
19.12 GE HEALTHCARE 224
- 19.12.1 COMPANY SNAPSHOT 224
- 19.12.2 REVENUE ANALYSIS 224
- 19.12.3 PRODUCT PORTFOLIO 225
- 19.12.4 RECENT DEVELOPMENT 225
19.13 HOLOGIC INC. 226
- 19.13.1 COMPANY SNAPSHOT 226
- 19.13.2 REVENUE ANALYSIS 226
- 19.13.3 PRODUCT PORTFOLIO 227
- 19.13.4 RECENT DEVELOPMENT 227
19.14 ILLUMINA, INC. 228
- 19.14.1 COMPANY SNAPSHOT 228
- 19.14.2 REVENUE ANALYSIS 228
- 19.14.3 PRODUCT PORTFOLIO 229
- 19.14.4 RECENT DEVELOPMENT 229
19.15 MEDONICA CO. LTD 230
- 19.15.1 COMPANY SNAPSHOT 230
- 19.15.2 PRODUCT PORTFOLIO 230
- 19.15.3 RECENT DEVELOPMENT 230
19.16 MERCK KGAA 231
- 19.16.1 COMPANY SNAPSHOT 231
- 19.16.2 REVENUE ANALYSIS 231
- 19.16.3 PRODUCT PORTFOLIO 232
- 19.16.4 RECENT DEVELOPMENT 232
19.17 MINFOUND MEDICAL SYSTEMS CO., LTD 233
- 19.17.1 COMPANY SNAPSHOT 233
- 19.17.2 PRODUCT PORTFOLIO 233
- 19.17.3 RECENT DEVELOPMENT 233
19.18 MYRIAD GENETICS, INC. 234
- 19.18.1 COMPANY SNAPSHOT 234
- 19.18.2 REVENUE ANALYSIS 234
- 19.18.3 PRODUCT PORTFOLIO 235
- 19.18.4 RECENT DEVELOPMENT 235
19.19 PLEXBIO 236
- 19.19.1 COMPANY SNAPSHOT 236
- 19.19.2 PRODUCT PORTFOLIO 236
- 19.19.3 RECENT DEVELOPMENT 236
19.20 QIAGEN 237
- 19.20.1 COMPANY SNAPSHOT 237
- 19.20.2 REVENUE ANALYSIS 237
- 19.20.3 PRODUCT PORTFOLIO 238
- 19.20.4 RECENT DEVELOPMENT 238
19.21 QUEST DIAGNOSTICS INCORPORATED 239
- 19.21.1 COMPANY SNAPSHOT 239
- 19.21.2 REVENUE ANALYSIS 239
- 19.21.3 PRODUCT PORTFOLIO 240
- 19.21.4 RECENT DEVELOPMENT 240
19.22 SIEMENS HEALTHCARE GMBH 241
- 19.22.1 COMPANY SNAPSHOT 241
- 19.22.2 REVENUE ANALYSIS 241
- 19.22.3 PRODUCT PORTFOLIO 242
- 19.22.4 RECENT DEVELOPMENT 242

19.23 STERNMED GMBH 243
- 19.23.1 COMPANY SNAPSHOT 243
- 19.23.2 PRODUCT PORTFOLIO 243
- 19.23.3 RECENT DEVELOPMENT 243
19.24 TIME MEDICAL HOLDING. 244
- 19.24.1 COMPANY SNAPSHOT 244
- 19.24.2 PRODUCT PORTFOLIO 244
- 19.24.3 RECENT DEVELOPMENT 244

20 QUESTIONNAIRE 245

21 RELATED REPORTS 249

LIST OF TABLES

TABLE 1 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
TABLE 2 EUROPE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 65
TABLE 3 EUROPE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 66
TABLE 4 EUROPE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 66
TABLE 5 EUROPE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
TABLE 6 EUROPE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 68
TABLE 7 EUROPE CONSUMABLES AND ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 8 EUROPE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 9 EUROPE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 70
TABLE 10 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 74
TABLE 11 EUROPE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 75
TABLE 12 EUROPE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
TABLE 13 EUROPE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 14 EUROPE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 77
TABLE 15 EUROPE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 16 EUROPE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 79
TABLE 17 EUROPE OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 80
TABLE 18 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 84
TABLE 19 EUROPE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
TABLE 20 EUROPE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 86
TABLE 21 EUROPE LARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 87
TABLE 22 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 91
TABLE 23 EUROPE STAGE III IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
TABLE 24 EUROPE STAGE II IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 25 EUROPE STAGE IV IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 26 EUROPE STAGE I IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 27 EUROPE STAGE 0 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 28 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 99
TABLE 29 EUROPE 30-65 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 100
TABLE 30 EUROPE 65 AND ABOVE IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 31 EUROPE 21-29 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 32 EUROPE BELOW 21 IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 33 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 106
TABLE 34 EUROPE HOSPITAL IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
TABLE 35 EUROPE ASSOCIATED LABS IN THROAT CANCER DIAGNOSTICS MARKET, 2021-2030 (USD MILLION) 108
TABLE 36 EUROPE INDEPENDENT DIAGNOSTIC LABORATORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 108
TABLE 37 EUROPE DIAGNOSTIC IMAGING CENTERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 109
TABLE 38 EUROPE CANCER RESEARCH INSTITUTES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
TABLE 39 EUROPE OTHERS IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 111
TABLE 40 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 115
TABLE 41 EUROPE DIRECT TENDER IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 116
TABLE 42 EUROPE RETAIL SALES IN THROAT CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 117
TABLE 43 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 124
TABLE 44 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 45 EUROPE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
TABLE 46 EUROPE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 47 EUROPE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 48 EUROPE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 49 EUROPE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 50 EUROPE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 51 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 126
TABLE 52 EUROPE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 126
TABLE 53 EUROPE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 54 EUROPE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
TABLE 55 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 127
TABLE 56 EUROPE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 127
TABLE 57 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 128
TABLE 58 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 128
TABLE 59 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 128
TABLE 60 EUROPE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 128
TABLE 61 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 62 GERMANY INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 63 GERMANY PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
TABLE 64 GERMANY IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 65 GERMANY CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 66 GERMANY KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 67 GERMANY REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
TABLE 68 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
TABLE 69 GERMANY IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
TABLE 70 GERMANY BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
TABLE 71 GERMANY BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
TABLE 72 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 132
TABLE 73 GERMANY PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 132
TABLE 74 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 132
TABLE 75 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 132
TABLE 76 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 133
TABLE 77 GERMANY THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 133
TABLE 78 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 79 FRANCE INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 80 FRANCE PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
TABLE 81 FRANCE IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 82 FRANCE CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 83 FRANCE KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 84 FRANCE REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
TABLE 85 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
TABLE 86 FRANCE IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
TABLE 87 FRANCE BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
TABLE 88 FRANCE BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
TABLE 89 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 137
TABLE 90 FRANCE PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 137
TABLE 91 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 137
TABLE 92 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 137
TABLE 93 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 138
TABLE 94 FRANCE THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 138
TABLE 95 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 96 U.K. INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 97 U.K. PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
TABLE 98 U.K. IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 99 U.K. CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 100 U.K. KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 101 U.K. REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
TABLE 102 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
TABLE 103 U.K. IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
TABLE 104 U.K. BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
TABLE 105 U.K. BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
TABLE 106 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 142
TABLE 107 U.K. PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 142
TABLE 108 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 142
TABLE 109 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 142
TABLE 110 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 143
TABLE 111 U.K. THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 143
TABLE 112 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
TABLE 113 ITALY INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
TABLE 114 ITALY PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 144
TABLE 115 ITALY IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 116 ITALY CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 117 ITALY KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 118 ITALY REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
TABLE 119 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
TABLE 120 ITALY IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
TABLE 121 ITALY BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
TABLE 122 ITALY BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 146
TABLE 123 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 147
TABLE 124 ITALY PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 147
TABLE 125 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 147
TABLE 126 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 147
TABLE 127 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 148
TABLE 128 ITALY THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 148
TABLE 129 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 130 SPAIN INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 131 SPAIN PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 149
TABLE 132 SPAIN IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 133 SPAIN CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 134 SPAIN KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 135 SPAIN REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
TABLE 136 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
TABLE 137 SPAIN IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
TABLE 138 SPAIN BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
TABLE 139 SPAIN BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 151
TABLE 140 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 152
TABLE 141 SPAIN PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 152
TABLE 142 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 152
TABLE 143 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 152
TABLE 144 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 153
TABLE 145 SPAIN THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 153
TABLE 146 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
TABLE 147 RUSSIA INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
TABLE 148 RUSSIA PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
TABLE 149 RUSSIA IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 150 RUSSIA CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 151 RUSSIA KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 152 RUSSIA REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
TABLE 153 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
TABLE 154 RUSSIA IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
TABLE 155 RUSSIA BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
TABLE 156 RUSSIA BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 156
TABLE 157 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 157
TABLE 158 RUSSIA PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 157
TABLE 159 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 157
TABLE 160 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 157
TABLE 161 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 158
TABLE 162 RUSSIA THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 158
TABLE 163 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
TABLE 164 TURKEY INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
TABLE 165 TURKEY PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
TABLE 166 TURKEY IMAGING INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 167 TURKEY CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 168 TURKEY KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 169 TURKEY REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
TABLE 170 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
TABLE 171 TURKEY IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
TABLE 172 TURKEY BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
TABLE 173 TURKEY BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 161
TABLE 174 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 162
TABLE 175 TURKEY PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 162
TABLE 176 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 162
TABLE 177 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 162
TABLE 178 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 163
TABLE 179 TURKEY THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 163
TABLE 180 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
TABLE 181 NETHERLANDS INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
TABLE 182 NETHERLANDS PATHOLOGY-BASED INSTRUMENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
TABLE 183 NETHERLANDS CONSUMABLES & ACCESSORIES IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 184 NETHERLANDS KITS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 185 NETHERLANDS REAGENTS IN THROAT CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 165
TABLE 186 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
TABLE 187 NETHERLANDS IMAGING TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
TABLE 188 NETHERLANDS BLOOD TEST IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
TABLE 189 NETHERLANDS BIOPSY IN THROAT CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
TABLE 190 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 166
TABLE 191 NETHERLANDS PHARYNGEAL CANCER IN THROAT CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 167
TABLE 192 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 167
TABLE 193 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 167
TABLE 194 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 168
TABLE 195 NETHERLANDS THROAT CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 168

LIST OF FIGURES

FIGURE 1 EUROPE THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 29
FIGURE 2 EUROPE THROAT CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 32
FIGURE 3 EUROPE THROAT CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 33
FIGURE 4 EUROPE THROAT CANCER DIAGNOSTICS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 34
FIGURE 5 EUROPE THROAT CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 34
FIGURE 6 EUROPE THROAT CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 36
FIGURE 7 EUROPE THROAT CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 37
FIGURE 8 EUROPE THROAT CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 38
FIGURE 9 EUROPE THROAT CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 39
FIGURE 10 EUROPE THROAT CANCER DIAGNOSTICS MARKET: SEGMENTATION 43
FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THROAT CANCER IS EXPECTED TO DRIVE THE EUROPE THROAT CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 44
FIGURE 12 THE INSTRUMENT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE THROAT CANCER DIAGNOSTICS MARKET IN 2023 & 2030 44
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE THROAT CANCER DIAGNOSTICS MARKET 53
FIGURE 14 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 60
FIGURE 15 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 61
FIGURE 16 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 61
FIGURE 17 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 62
FIGURE 18 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 70
FIGURE 19 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 71
FIGURE 20 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 71
FIGURE 21 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 72
FIGURE 22 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 80
FIGURE 23 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 81
FIGURE 24 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 81
FIGURE 25 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 82
FIGURE 26 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 87
FIGURE 27 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 88
FIGURE 28 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 88
FIGURE 29 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 89
FIGURE 30 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 95
FIGURE 31 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 96
FIGURE 32 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 96
FIGURE 33 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 97
FIGURE 34 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2022 102
FIGURE 35 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 103
FIGURE 36 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 103
FIGURE 37 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 104
FIGURE 38 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 111
FIGURE 39 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 112
FIGURE 40 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 112
FIGURE 41 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 113
FIGURE 42 EUROPE THROAT CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 118
FIGURE 43 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 120
FIGURE 44 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 120
FIGURE 45 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 121
FIGURE 46 EUROPE THROAT CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE (2023-2030) 121
FIGURE 47 EUROPE THROAT CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 178